Indications and uses
①clean and dry affected area. ②Peel protective film from patch and apply it to the skin. ③Apply to affected area not more than 3 times daily. ④Remove patch from the skin after about 8 hours' application.
Moxibustion patch
- Manufacturer
- Henan Duoduohui Supply Chain Management Co., Ltd.
- Effective date
- 2024-10-16
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 00:26:14
Label at a glance#
ProductMoxibustion patch
Active ingredientARTEMISIA ARGYI LEAF
Label structure11 sections
Dosage and administration
①External use only.② Don't use otherwise than as directed. ③Avoid contacting with the eyes, mucous membranes or rashes ④Stop using at least 1 hour before or after a bath.
Label contents#
Full prescribing information#
Active ingredients
ARTEMISIA ARGYI LEAF 10%
Purpose
Relieve joint pain: Ai Cao Tie is often used to relieve joint pain caused by rheumatism, arthritis, or other reasons.
Improving muscle pain: For problems such as muscle soreness, sprains, strains, etc., mugwort patches can also have a certain soothing effect.
Promote blood circulation: Ai Cao Tie can help improve local blood circulation and promote smooth circulation of qi and blood.
Expelling Cold and Dampness: In traditional Chinese medicine theory, mugwort has the effect of dispelling cold and dampness, and is suitable for discomfort caused by cold and dampness
Uses
①clean and dry affected area.
②Peel protective film from patch and apply it to the skin.
③Apply to affected area not more than 3 times daily.
④Remove patch from the skin after about 8 hours' application.
Warnings
①Rash,itching or excessive skin irritation develops.
②symptoms persist for more than 7 days or worsen.
③Symptoms clearup and occur again within a few days.
Dosage and administration
①External use only.② Don't use otherwise than as directed.
③Avoid contacting with the eyes, mucous membranes or rashes
④Stop using at least 1 hour before or after a bath.
Do not use
①Rash,itching or excessive skin irritation develops.
②symptoms persist for more than 7 days or worsen.
③Symptoms clearup and occur again within a few days.
When using section
①External use only.② Don't use otherwise than as directed.
③Avoid contacting with the eyes, mucous membranes or rashes
④Stop using at least 1 hour before or after a bath.
stop use
① On wounds or damaged skin.
②lf you are allergic to any ingredients of this product.
③lf pregnant or breast-feeding or under 18 years old.
Keep out of reach of children.
Please keep this product out of reach of children. If ingested, seek medical assistance immediately or contact a toxicology center.
Inactive ingredients
ZINGIBER OFFICINALE WHOLE EXTRACT，EUPHORBIA SIEBOLDIANA ROOT，BORNEOL，PANAX NOTOGINSENG TOP
PRINCIPAL DISPLAY PANEL
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84842-001-01 | Moxibustion patch | 24 g in 1 BOX | PATCH | 24 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Moxibustion patch
- ARTEMISIA ARGYI LEAF
- EUPHORBIA SIEBOLDIANA ROOT
- BORNEOL
- PANAX NOTOGINSENG TOP
- ZINGIBER OFFICINALE WHOLE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 84842-001 | 84842-001-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ARTEMISIA ARGYI LEAF | 2JYC99Q0WZ | ACTIB |
| EUPHORBIA SIEBOLDIANA ROOT | NVE6JW2WWB | IACT |
| BORNEOL | M89NIB437X | IACT |
| PANAX NOTOGINSENG TOP | IQC2WQS369 | IACT |
| ZINGIBER OFFICINALE WHOLE | IN6Q3S3414 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 24948d59-192c-ffbe-e063-6294a90ae0ff | 24948d59-192b-ffbe-e063-6294a90ae0ff | 2024-10-16 | Warnings | 24948d59-192c-ffbe-e063-6294a90ae0ff 24948d59-192b-ffbe-e063-6294a90ae0ff |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.